# Dietary fatty acid intake and gut microbiota determine circulating endocannabinoidome signaling beyond the effect of body fat

**Authors:** Sophie Castonguay-Paradis, Sébastien Lacroix, Gabrielle Rochefort, Lydiane Parent, Julie Perron, Cyril Martin, Benoît Lamarche, Frédéric Raymond, Nicolas Flamand, Vincenzo Di Marzo, Alain Veilleux

PMC · DOI: 10.1038/s41598-020-72861-3 · 2020-09-29

## TL;DR

Diet and gut bacteria influence endocannabinoid levels in the blood, independent of body fat.

## Contribution

Identifies diet and gut microbiota as key factors affecting endocannabinoid signaling beyond body fat.

## Key findings

- Dietary fatty acids and gut bacteria are linked to endocannabinoid levels regardless of body fat.
- A Mediterranean diet increased NAE and 2-MAG levels in line with changes in fatty acid intake.
- Certain gut bacterial families correlate with specific endocannabinoid derivatives independently of fat mass.

## Abstract

The endocannabinoidome encompasses several fatty acid (FA)-derived mediators, including the endocannabinoid anandamide (AEA) and 2-arachidonoyl-glycerol (2-AG), which served as targets for anti-obesity drug development, and their congener N-acyl-ethanolamines (NAEs) and 2-monoacyl-glycerols (2‑MAGs), which are involved in food intake and energy metabolism. Body weight and fat distribution have been suggested as determinants of peripheral endocannabinoid levels. We aimed at investigating factors, beyond body fat composition, that are associated with circulating NAE and 2-MAG levels in a heterogeneous human population. Plasma NAEs and 2-MAGs were measured using LC–MS/MS in a cross-sectional sample of healthy men and women (n = 195) covering a wide range of BMI and individuals before and after a 2-day Mediterranean diet (n = 21). Circulating levels of all 2-MAGs and NAEs, other than N-oleoyl-ethanolamine (OEA), correlated with body fat mass and visceral adipose tissue (0.26 < r < 0.54). NAE levels were elevated in individuals with elevated fat mass, while 2-MAGs were increased in individuals with predominantly visceral body fat distribution. Dietary intakes of specific FAs were associated with 2-AG and omega-3-FA-derived NAEs or 2-MAGs, irrespective of the body fat distribution. Some gut bacterial families (e.g. Veillonellaceae, Peptostreptococcaceae and Akkermansiaceae) were associated with variations in most NAEs or omega-3-FA-derived 2‑MAGs, independently of fat mass and dietary FA intake. Finally, a 2-day Mediterranean diet intervention increased circulating levels of NAEs and 2-MAGs in agreement with changes in FA intake (p < 0.01). Self-reported intake and short-term dietary intervention increased in oleic acid and EPA and DHA intake as well as certain gut microbiota taxa are associated to circulating NAEs and 2‑MAGs independently of adiposity measures, thus highlighting the potential importance of these variables in determining endocannabinoidome signaling in humans.

## Linked entities

- **Chemicals:** anandamide (PubChem CID 5281969), 2-arachidonoyl-glycerol (PubChem CID 5282280), oleic acid (PubChem CID 445639), EPA (PubChem CID 446284), DHA (PubChem CID 15608515)

## Full-text entities

- **Genes:** PPARA (peroxisome proliferator activated receptor alpha) [NCBI Gene 5465] {aka NR1C1, PPAR, PPAR-alpha, PPARalpha, hPPAR}, CNR2 (cannabinoid receptor 2) [NCBI Gene 1269] {aka CB-2, CB2, CX5}, GPR119 (G protein-coupled receptor 119) [NCBI Gene 139760] {aka GPCR2}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, TRPV1 (transient receptor potential cation channel subfamily V member 1) [NCBI Gene 7442] {aka VR1}, CNR1 (cannabinoid receptor 1) [NCBI Gene 1268] {aka CANN6, CB-R, CB1, CB1A, CB1K5, CB1R}, GPR55 (G protein-coupled receptor 55) [NCBI Gene 9290] {aka LPIR1}
- **Diseases:** enteropathies (MESH:C538273), metabolic diseases (MESH:D008659), AEA (MESH:C562651), prediabetes (MESH:D011236), gut dysbiosis (MESH:D064806), nutritional deficiencies (MESH:D044342), Adiposity (MESH:D018205), type 2 diabetes (MESH:D003924), Overweight (MESH:D050177), inflammatory bowel disease (MESH:D015212), visceral adiposity (MESH:D007418), Obesity (MESH:D009765)
- **Chemicals:** glucose (MESH:D005947), N-palmitoyl-ethanolamine (MESH:C005958), propionate (MESH:D011422), FA (MESH:D005227), Monoacyl-glycerol (MESH:D050178), 2-AG (MESH:C094503), 2-LG (MESH:C114955), N-acylphosphatidylethanolamine (MESH:C000609813), oleic acid (MESH:D019301), DHEA (MESH:C000628804), fat (MESH:D005223), palmitic acids (MESH:D010169), N-acyl-ethanolamines (MESH:C022203), Endocannabinoids (MESH:D063388), 2-OG (MESH:C505247), sugar (MESH:D000073893), AEA (MESH:C078814), omega-3 PUFA (MESH:D015525), alcohol (MESH:D000438), phospholipids (MESH:D010743), DHA (MESH:C027493), N-oleoyl-ethanolamine (MESH:C000707817), arachidonic acid (MESH:D016718), 2-docosapentaenoyl-glycerol (-), -DPG (MESH:C027773), PUFA (MESH:D005231), ethanolamine (MESH:D019856), linoleic acid (MESH:D019787), oil (MESH:D009821), lipid (MESH:D008055), 2-PG (MESH:C114956), phosphatidylethanolamine (MESH:C483858),  (MESH:D004041),  (MESH:D001095),  (MESH:D053284),  (MESH:D005989)
- **Species:** Homo sapiens (human, species) [taxon 9606], Akkermansia muciniphila (species) [taxon 239935], Phascolarctobacterium (genus) [taxon 33024], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** R24W
- **Cell lines:** S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232)

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC7524791/full.md

---
Source: https://tomesphere.com/paper/PMC7524791